Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels

Background and Aims: Intermediate stage hepatocellular carcinoma (HCC) can be treated by transarterial chemoembolization (TACE). However, there appear to be side effects, such as induction of proangiogenic factors, e.g. vascular endothelial growth factor (VEGF), which have been shown to be associate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Transl Hepatol
Egile Nagusiak: Schicho, Andreas, Hellerbrand, Claus, Krüger, Kristina, Beyer, Lukas P., Wohlgemuth, Walter, Niessen, Christoph, Hohenstein, Ernst, Stroszczynski, Christian, Pereira, Philippe L., Wiggermann, Philipp
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: XIA & HE Publishing Inc. 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225147/
https://ncbi.nlm.nih.gov/pubmed/28097096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00058
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak